Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: 0.17 + web + 20,800  Related to the article below (Last Update: 8/4/2008)

Triad Guaranty Inc. Reports Second Quarter Loss as Reported ...
MarketWatch -
For more information, please visit the Company's web site at www.triadguaranty.com. Diluted realized investment gains (losses) per share, net of taxes, ...TGIC
College of Art Buys Area Homes
Memphis Daily News,  USA -
Last month it spent $175000 for the 2040-square-foot home that sits on 0.17 acres at 148 N. Tucker St.; $187000 for the 2232-square-foot home that sits on ...
Lydall Announces Financial Results for the Second Quarter and Six ...
CNNMoney.com -
The call may be accessed in a listen-only mode at 877-440-5804 and will be webcast live on the Company's web site www.lydall.com under the Investor ...LDL
Equity One Reports Second Quarter 2008 Operating Results
WELT ONLINE, Germany - Jul 29, 2008
CONFERENCE CALL/WEB CAST INFORMATION We will host a conference call on Wednesday, July 30, 2008, at 9:00 am EST to review the 2008 second quarter earnings ...EQY - COL:EQIT
BlueLinx Announces Second-Quarter Results
MarketWatch - Jul 30, 2008
Investors can listen to the conference call and view the accompanying slide presentation by going to the BlueLinx web site, www. ...
thinkorswim Group Inc. Reports Second Quarter Financial Results CNNMoney.com (press release)
Fiserv Reports Second Quarter 2008 Results Trading Markets (press release)
TSMC Reports Second Quarter EPS of NT$1.12 PR Newswire (press release)
MarketWatch
all 283 news articles »  BXC - TSM - NXTY
Firefox 3 chipping away Safari market share, summer browsing ...
TG Daily - Aug 1, 2008
... most notably Apple's Safari (which showed a 0.17 point decline in July), Opera (0.04 point decline), and other web browsers, possible earlier Firefox ...
Actel Announces Second Quarter 2008 Financial Results
CNNMoney.com - Jul 29, 2008
A live web cast and replay of the call will be available. Web cast and replay access information as well as financial and other statistical information can ...ACTL
June 2008 Quarterly Activities and Cashflow Report
Sydney Morning Herald, Australia - Jul 21, 2008
The results were reported during the June quarter and included the following excellent intersections: BL08-15: 68.60m @ 1.29g/t Pt+Pd, 0.17% Cu & 0.17% Ni ...ASX:MMB
Euronet Worldwide Reports Second Quarter 2008 Financial Results
FOXBusiness - Jul 30, 2008
Participants should go to the Web site at least 5 minutes prior to the scheduled start time of the event to register. A slideshow will accompany the webcast ...EEFT
Geron Corporation Reports 2008 Second Quarter Financial Results ...
MarketWatch - Jul 30, 2008
For the second quarter of 2008, the company reported a net loss of $13.6 million, or $(0.17) per share, compared to $14.0 million, or $(0.19) per share, ...GERN
Source: Google News

Web Impact Factors for Iranian Universities -
A Noruzi - Webology, 2005 - webology.ir
... 2.95, 40100, 39500, 367, 13600, 2.90, 20800, 10600, 22100. ... University, 1.71, 22400,
2260, 8900, 13100, 0.17, 1680, 7170, ... Table 7. Web Impact Factors for Iranian university ...

[PDF] … Accumulation of Polychlorinated Biphenyl Congeners in the Aquatic Food Web at the Kalamazoo River … -
DP Kay, AL Blankenship, KK Coady, AM Neigh, MJ … - Environmental Science & Technology, 2005 - usask.ca
... of lipid- or organic-carbon-normalized total PCB concentrations in the tree swallow
food web at FC was ... trichoptera 1 10.9 1.17 (1.17) 4 4.34 0.17 ( 0.04 (0.164) ...

[PDF] … Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial Food Web of the Kalamazoo … -
AL Blankenship, MJ Zwiernik, KK Coady, DP Kay, JL … - Environmental Science & Technology, 2005 - msu.edu
Differential Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial
Food Web of the ... This study focused on two locations for food web analysis. ...

[CITATION] Calder Continuous Query Grid Service
N Vijayakumar, Y Liu, B Plale
-

A new bridging ligand for the synthesis of luminescent polynuclear Ru (II) and Os (II) polypyridine … -
A B?rje, O K?the, A Juris - New Journal of Chemistry, 2001 - rsc.org
... Published on the Web 19th January 2001. ... 2 Ru( -bpy-O-bpy)Os(bpy) 2 ](PF 6 ) 4,
455(20800), 753, 23, ... mmol), HO-bpy (0.060 mmol), and dried K 2 CO 3 (0.17 mmol) were ...

-
BG Klowak? - US Patent 4,849,054, 1989 - Google Patents
... satisfying, in absolute values, the relationships (0.27 BW-1) TS>(0.17 BW- 1 ... method
of manufacturing the product comprising wet pressing a fibrous web to about ...

Multielemental analysis of Mn?Fe nodules by ICP-MS: optimisation of analytical method -
MD Axelsson, I Rodushkin, J Ingri, B ?hlander - The Analyst, 2002 - rsc.org
... First published on the web 10th December 2001. ... Max, ICP-SFMS, s a, Min, Max. Ag,
0.17, 0.02, <5, 0.21, 0.03, <5, Al, 20800, 300, 20480, 17000, 32600, 24600, 1000 ...

Characterisation of trace elements and methylmercury in an estuarine sediment reference material, … -
EJ Wyse, M Coquery, S Azemard, SJ Mora - Journal of Environmental Monitoring, 2004 - rsc.org
... First published on the web 8th December 2003. ... Ca, 3, 13700?24900, 20800, 6200, 29.8,
4, 22, 23263, 7020, 13700 ... Tb, 3, 0.803?1.128, 0.93, 0.507?1.360, 0.17, 18.4, ...

The Precordial Movements in Adults with Pulmonic Stenosis -
JH HOLT, EE EDDLEMAN - Circulation, 1967 - Am Heart Assoc
... http://circ.ahajournals.org services, is located on the World Wide Web at: The online
version of this article, along with updated information and ...

Microflora, Protozoa and Nematoda in Lumbricus terrestris burrow walls: a laboratory experiment -
AV Tiunov, M Bonkowski, M Bonkowski, JA Tiunov, S … - Pedobiologia-International Journal of Soil Biology, 2001 - Elsevier
... the soil is widely accepted, but little is known about its influence on subsequent
food web components, particularly ... Amoebae 10800 ac 44600 b 5900 c 20800 ab ...

Source: Google Scholar
 
 

Doxycycline slows progression of knee osteoarthritis

 

 
A study showed effectiveness of Doxycycline in slowing disease progression in patients with osteoarthritis.

Doxycycline, a tetracycline antibiotic, has been successfully used to treat a wide-range of bacterial infections.
In addition to its effects as an antibiotic, Doxycycline has other actions as a drug and, in laboratory studies with animals and with human tissue, can inhibit the degradation of cartilage in a way that could be useful for the treatment of osteoarthritis ( OA ).

Osteoarthritis is a common form of arthritis associated with pain and disability related to the breakdown of cartilage, the tissue in the joint that absorbs shock and promotes smooth movement .

On base of preclinical evidence, a team of rheumatologists affiliated with six clinical research centers across the United States conducted the first long-term clinical trial to determine the benefits of Doxycycline in the treatment of osteoarthritis, particularly, osteoarthritis of the knee.

The study suggests that Doxycycline may slow the progression of joint damage and point to the need for further research into the drug's effect on the signs and symptoms of this disease.

For the trial, the team recruited 431 overweight women between the ages of 45 and 64 with moderately advanced osteoarthritis in one knee.

The subjects were randomly assigned to receive either 100 milligrams of Doxycycline or a placebo twice a day for 30 months.

At baseline, the 2 treatment groups were roughly equal with respect to all demographic variables, body mass index, and types of drugs taken for pain, as well as for the x-ray severity of osteoarthritis in the affected knee and the level of knee pain and functional impairment.

Osteoarthritis progression was assessed by measuring joint space narrowing in the medial tibiofemoral compartment through X-rays obtained at baseline, 16 months and 30 months. Severity of joint pain was assessed every 6 months after a washout period of all nonsteroidal anti-inflammatory drugs ( NSAIDs ) and analgesics.

71 percent of the subjects completed the treatment protocol.
Radiographs were obtained from 85 percent of all subjects at 30 months.
After 16 months of treatment, the mean loss of joint space width in the diseased knee in the Doxycycline group was 40 percent less than in the placebo group.
After 30 months, it was 33 percent less.
Despite significantly slowing disease progression, Doxycycline did not reduce the severity of joint pain.
However, mean pain scores at baseline were low in both treatment groups, leaving only limited opportunity to demonstrate improvement in joint pain.
On the other hand, the drug significantly reduced the frequency with which subjects reported increases in knee pain 20 percent or greater than the level of pain they had at their previous semi-annual visit.

Doxycycline seemed to have no effect on joint space narrowing or pain in the relatively disease-free knee.
In both knees in both treatment groups, the rate of joint space narrowing was more than twice as rapid in subjects who reported frequent increases in pain than in those with a stable pain score.

"Joint pain may serve as an indicator of synovitis that leads to cartilage destruction," observes the study's leading author, Kenneth D. Brandt.

Throughout the trial, fewer than 5 percent of all subjects reported side effects.
In general, Doxycycline seemed to be well tolerated.
Subjects in the active treatment group experienced the unexpected side benefits of fewer urinary tract and upper respiratory tract infections than their placebo counterparts.

In this study, Doxcycyline showed benefits in slowing the rate of joint space narrowing in knees with established osteoarthritis.
Whether this drug has any value in the early treatment and symptomatic management of osteoarthritis, however, will require further investigation.

Source: Arthritis & Rheumatism, 2005
 
 
 
Google
Web www.iconocast.com
 
 
 

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page